These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39415134)

  • 1. Trends in viral load suppression among HIV patients on antiretroviral therapy (ART) at Asante Mampong Municipal Hospital, Ghana: 2019-2023.
    Kyere GA; Vechey GA; Charles-Unadike VO; Tarkang EE
    BMC Infect Dis; 2024 Oct; 24(1):1170. PubMed ID: 39415134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral load suppression after intensive adherence counselling among adult people living with HIV at Kiswa health centre, Kampala: a retrospective cohort study. Secondary data analysis.
    Nakaye C; Mukiza N; Mawanda D; Kataike H; Kaganzi H; Ahimbisibwe GM; Businge GB; Kyambadde RC; Nakalega R
    AIDS Res Ther; 2023 Mar; 20(1):18. PubMed ID: 36998004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA/MMH), 2019 to 2020.
    Chicanequisso EM; Baltazar CS; Sacarlal J
    BMC Infect Dis; 2024 Jul; 24(1):713. PubMed ID: 39033267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of viral load non-suppression among adolescents in Mbale District, Eastern Rural Uganda.
    Maena J; Banke-Thomas A; Mukiza N; Kuteesa CN; Kakumba RM; Kataike H; Kizito S; Babirye JA; Nakalega R
    AIDS Res Ther; 2021 Dec; 18(1):91. PubMed ID: 34863196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.
    Ntombela NP; Kharsany ABM; Soogun A; Yende-Zuma N; Baxter C; Kohler HP; McKinnon LR
    Reprod Health; 2022 May; 19(1):116. PubMed ID: 35550580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
    Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
    BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictors of unsuppressed viremia among PLHIV: a cross-sectional study in Ghana.
    Owusu LB; Ababio C; Boahene S; Zakaria AS; Emikpe AO; Dwumfour CK; Appiagyei KA; Apiribu F
    BMC Public Health; 2023 Jun; 23(1):1113. PubMed ID: 37296400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-uptake of viral load testing among people receiving HIV treatment in Gomba district, rural Uganda.
    Nakalega R; Mukiza N; Kiwanuka G; Makanga-Kakumba R; Menge R; Kataike H; Maena J; Akello C; Atuhaire P; Matovu-Kiweewa F; Ndikuno-Kuteesa C; Debem H; Mujugira A
    BMC Infect Dis; 2020 Oct; 20(1):727. PubMed ID: 33023498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with viral load non-suppression in people living with HIV on ART in Nigeria: cross-sectional analysis from 2017 to 2021.
    Tomescu S; Crompton T; Adebayo J; Akpan F; Dauda DS; Allen Z; Ondura EO; Wose Kinge C; Chasela C; Pisa P
    BMJ Open; 2023 May; 13(5):e065950. PubMed ID: 37169497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
    Kahabuka MS; Woldeamanuel Y; Mbelele PM; Mpolya EA; Mpagama SG; Kessy JP; Manyazewal T
    BMC Infect Dis; 2024 Apr; 24(1):390. PubMed ID: 38605325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
    Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
    Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?
    Euvrard J; Schulz T; Hilderbrand K; Bosland M; Osler M; Boulle A; Davies MA
    S Afr Med J; 2019 Feb; 109(3):174-177. PubMed ID: 30834874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic and virological response to ART among HIV infected individuals at a tertiary hospital in Ghana.
    Obiri-Yeboah D; Pappoe F; Baidoo I; Arthur F; Hayfron-Benjamin A; Essien-Baidoo S; Kwakye-Nuako G; Ayisi Addo S
    BMC Infect Dis; 2018 May; 18(1):230. PubMed ID: 29783953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018.
    Mhlanga TT; Jacobs BKM; Decroo T; Govere E; Bara H; Chonzi P; Sithole N; Apollo T; Van Damme W; Rusakaniko S; Lynen L; Makurumidze R
    AIDS Res Ther; 2022 Jul; 19(1):34. PubMed ID: 35810317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
    Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
    PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV viral load non-suppression and associated factors among pregnant and postpartum women in rural northeastern South Africa: a cross-sectional survey.
    Ngandu NK; Lombard CJ; Mbira TE; Puren A; Waitt C; Prendergast AJ; Tylleskär T; Van de Perre P; Goga AE
    BMJ Open; 2022 Mar; 12(3):e058347. PubMed ID: 35273061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana.
    Opoku S; Sakyi SA; Ayisi-Boateng NK; Enimil AK; Senu E; Ansah RO; Aning BD; Ojuang DA; Wekesa DN; Ahmed FO; Okeke CB; Sarfo AD
    AIDS Res Ther; 2022 May; 19(1):21. PubMed ID: 35614510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and viral suppression of hepatitis B virus infection among people living with HIV on antiretroviral therapy in Sierra Leone.
    Song JW; Lakoh S; Chen SY; Jalloh MB; Sevalie S; Baldeh M; Nyambe MK; Nicholas VD; Yendewa G; Wang FS; Yang G
    Sex Transm Infect; 2024 Jul; 100(5):264-270. PubMed ID: 38789266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.